PMC:7445716 / 76407-76875 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T698","span":{"begin":36,"end":44},"obj":"Disease"},{"id":"T699","span":{"begin":211,"end":219},"obj":"Disease"},{"id":"T700","span":{"begin":231,"end":234},"obj":"Disease"},{"id":"T701","span":{"begin":283,"end":286},"obj":"Disease"},{"id":"T702","span":{"begin":322,"end":330},"obj":"Disease"}],"attributes":[{"id":"A698","pred":"mondo_id","subj":"T698","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A699","pred":"mondo_id","subj":"T699","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A700","pred":"mondo_id","subj":"T700","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A701","pred":"mondo_id","subj":"T701","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A702","pred":"mondo_id","subj":"T702","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"of a systemic inflammatory storm in COVID-19 [76, 77]. However, given the limited data, we could not perform an accurate analysis of the distribution and, eventually, prognostic value of inflammatory markers in COVID-19-associated GBS. Moreover, we cannot exclude that in cases with GBS developing before or together with COVID-19 symptoms, the disease might have progressed sub-clinically in the early phase to manifest afterwards with its typical systemic clinical p"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T694","span":{"begin":3,"end":4},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"of a systemic inflammatory storm in COVID-19 [76, 77]. However, given the limited data, we could not perform an accurate analysis of the distribution and, eventually, prognostic value of inflammatory markers in COVID-19-associated GBS. Moreover, we cannot exclude that in cases with GBS developing before or together with COVID-19 symptoms, the disease might have progressed sub-clinically in the early phase to manifest afterwards with its typical systemic clinical p"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1156","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"1157","span":{"begin":210,"end":218},"obj":"Disease"},{"id":"1158","span":{"begin":321,"end":329},"obj":"Disease"}],"attributes":[{"id":"A1156","pred":"tao:has_database_id","subj":"1156","obj":"MESH:C000657245"},{"id":"A1157","pred":"tao:has_database_id","subj":"1157","obj":"MESH:C000657245"},{"id":"A1158","pred":"tao:has_database_id","subj":"1158","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"of a systemic inflammatory storm in COVID-19 [76, 77]. However, given the limited data, we could not perform an accurate analysis of the distribution and, eventually, prognostic value of inflammatory markers in COVID-19-associated GBS. Moreover, we cannot exclude that in cases with GBS developing before or together with COVID-19 symptoms, the disease might have progressed sub-clinically in the early phase to manifest afterwards with its typical systemic clinical p"}

{"project":"LitCovid-sentences","denotations":[{"id":"T457","span":{"begin":55,"end":235},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"of a systemic inflammatory storm in COVID-19 [76, 77]. However, given the limited data, we could not perform an accurate analysis of the distribution and, eventually, prognostic value of inflammatory markers in COVID-19-associated GBS. Moreover, we cannot exclude that in cases with GBS developing before or together with COVID-19 symptoms, the disease might have progressed sub-clinically in the early phase to manifest afterwards with its typical systemic clinical p"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1154","span":{"begin":36,"end":44},"obj":"SP_7"},{"id":"T1155","span":{"begin":211,"end":219},"obj":"SP_7"},{"id":"T1156","span":{"begin":322,"end":330},"obj":"SP_7"}],"text":"of a systemic inflammatory storm in COVID-19 [76, 77]. However, given the limited data, we could not perform an accurate analysis of the distribution and, eventually, prognostic value of inflammatory markers in COVID-19-associated GBS. Moreover, we cannot exclude that in cases with GBS developing before or together with COVID-19 symptoms, the disease might have progressed sub-clinically in the early phase to manifest afterwards with its typical systemic clinical p"}

{"project":"2_test","denotations":[{"id":"32840686-32529462-63205840","span":{"begin":45,"end":47},"obj":"32529462"},{"id":"32840686-32513566-63205841","span":{"begin":49,"end":51},"obj":"32513566"}],"text":"of a systemic inflammatory storm in COVID-19 [76, 77]. However, given the limited data, we could not perform an accurate analysis of the distribution and, eventually, prognostic value of inflammatory markers in COVID-19-associated GBS. Moreover, we cannot exclude that in cases with GBS developing before or together with COVID-19 symptoms, the disease might have progressed sub-clinically in the early phase to manifest afterwards with its typical systemic clinical p"}